Dr. Thomas L. Beaumont, MD, PhD

Dr. Beaumont practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Beaumont's NPI, 1497067573, was assigned on July 6, 2010. Dr. Beaumont graduated from Wayne State University School Of Medicine in 2010. Dr. Beaumont holds California license A159281.

Dr. Beaumont's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Beaumont's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Beaumont is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beaumont practices. Vendor and product names are available with a free account.

Neurological surgery is Dr. Beaumont's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Beaumont is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Beaumont's licenses on file in 3 states: California, Missouri and Ohio.

Dmand AI lists craniotomy among the conditions Dr. Beaumont treats.

CMS data shows 73 Medicare services from Dr. Beaumont across 4 procedure codes in 2024, all of them office visits, for 108 Medicare patients. Medicare paid $6,416 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Beaumont in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beaumont's median patient age at 56, with 60% women.

In 2024, Dr. Beaumont wrote 15 Medicare Part D claims. Every claim was for a generic drug. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $163 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Beaumont for performance year 2024, reported as part of a group. Dr. Beaumont accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beaumont as offering telehealth.

Dmand AI links 17 papers to Dr. Beaumont, published from 2012 to 2025. 2021 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Glioblastoma and Magnetic Resonance Imaging. Dr. Beaumont has published most often in J Neurosurg. Dr. Beaumont's most frequent co-authors are Vanessa Shareen Goodwill, MD, Eric Claude Leuthardt, MD and David Delmar Limbrick, MD.

CMS Open Payments shows 28 general payments to Dr. Beaumont from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Omniscient Neurotechnology America Ltd paid the most, $237.

Dr. Beaumont graduated from Wayne State University School Of Medicine in 2010.

Dr. Beaumont is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.